Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00252434 · ClinicalTrials.gov registry record · Phase 1
Behavioral Therapy Development for Methamphetamine Abuse
A Phase 1 study, sponsored by University of California, Los Angeles.
- Terminated
- Registry status
- Phase 1
- Development phase
NCT00252434: Clinical Trial Phase 1 study, sponsored by University of California, Los Angeles.
NCT00252434 is a Phase 1 study that was terminated before completion, run by University of California, Los Angeles. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00252434, a Phase 1 study, was terminated before completion, sponsored by University of California, Los Angeles.
- TERMINATED
- Registry status
- Phase 1
- Development phase
Study Summary
The purpose of this study is to evaluate whether a specially developed group counseling approach is better able to help HIV-positive gay and bisexual men (GBM) who use crystal meth to stop using methamphetamines, reduce sexual risk behaviors, and stay on their HIV medications than a standard drug treatment program. Another purpose is to determine whether having a drug abuse treatment program in an HIV medical clinic makes it easier to attend treatment than going to a separate location for drug abuse treatment.
Interventions
- BEHAVIORAL Cognitive Behavioral Therapy Development for Methamphetamine Abuse
Trial Details
| Field | Value |
|---|---|
| Start Date | 2004-08 |
| Est. Completion | 2007-11 |
| Phase | Phase 1 |
Why NCT00252434 stopped before completion
NCT00252434 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which Cognitive Behavioral Therapy Development for Methamphetamine Abuse is the first listed.
NCT00252434 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00252434 about?
NCT00252434 is a clinical study titled "Behavioral Therapy Development for Methamphetamine Abuse". The purpose of this study is to evaluate whether a specially developed group counseling approach is better able to help HIV-positive gay and bisexual men (GBM) who use crystal meth to stop using methamphetamines, reduce sexual risk behaviors, and stay on their HIV medications than a standard drug tr...
What is the current status of trial NCT00252434?
This trial is currently terminated. It is a Phase 1 study. The study started on 2004-08. Estimated completion is 2007-11.
What interventions are being tested in trial NCT00252434?
The interventions under investigation include: Cognitive Behavioral Therapy Development for Methamphetamine Abuse (BEHAVIORAL).
Who is sponsoring clinical trial NCT00252434?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia